An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy
Clinical trial NCT07525869 · RECRUITING
Trial details
- NCT number
- NCT07525869
- Sponsor
- Yonsei University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-28
- Primary completion
- 2026-10-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.